On Tuesday, Johnson & Johnson announced that it is discontinuing its iconic talc-based baby powder in the U.S. and Canada amid a larger review of products prompted by the COVID-19 pandemic.
The company, which faces thousands of lawsuits claiming the powder caused cancer in women who used it, said demand has been falling “due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” according to a statement.
Johnson & Johnson “remains steadfastly confident in the safety of talc-based Johnson’s Baby Powder,” according to the statement. “We will continue to vigorously defend the product, its safety, and the unfounded allegations against it and the Company in the courtroom. All verdicts against the Company that has been through the appeals process have been overturned,” the company said.
So, what does this mean for the company in the long-term?
Rebecca Rose Woodland, litigator, and legal analyst joined TheStreet to weigh in on the company.
Watch the video above for more.
You can follow Katherine Ross on Twitter at @byKatherineRoss.
Watch More of the Latest Videos from TheStreet and Jim Cramer
- May 17, 1792: The NYSE Is Founded in New York City
- Which Countries Have the Most Doctors?
- C-Suite: Blue Apron CEO: Using Stay-at-Home Tailwind to Grow Post-Virus
- Ask Bob: I Was Furloughed. Under the CARES Act, Do I Still Need to Pay My 401(k) Loans?
- Kitco News: How to Beat Unlimited Monetary Stimulus With Gold